Dexcom stock stock recovered Friday after the diabetes devices maker missed fourth-quarter profit expectations.

Much progress has been made in diabetes technology over the past decade. Continuous glucose monitoring has achieved high accuracy and reliability, resulting ...

Sales: The California-based device maker is pinning its hopes on Stelo, its recently launched device for adults aged 18 and ...

Discover how smartphones with advanced sensors are revolutionizing health monitoring. Explore ECG, SpO2 tracking, ...

People with type 1 diabetes require continuous insulin treatment and must regularly measure their glucose levels. With open-loop therapies, insulin administration is manually controlled, while hybrid ...

Looking forward, DexCom's management has reiterated its fiscal year 2025 forecast, anticipating revenue growth of 14% with a ...

Validic, a leader in healthcare technology innovation, announces the launch of its patent-pending solution, a cutting-edge digital remote patient moni ...

West Pharmaceutical Services Inc.'s stock tumbled 33% Thursday, to lead S&P 500 decliners, after the manufacturer of injectable-pharmaceutical packaging and delivery systems offered guidance for 2025 ...

Advanced sensing features are coming to wearables beginning in 2025 and Penn State’s device, made with laser-modified ...

Medtech companies have their eye on the growing hospital-at-home market, which is driven largely by the rising elderly ...

Motorists could be slapped with fines of up to £1,000 if they fail to tell the DVLA about certain health conditions that ...

Some motorists could be at risk of fines of up to £1,000 if they don't get in contact with the DVLA as soon as possible. A ...